Preferential killing of cancer cells using Silicon Carbide Quantum Dots

Journal of Nanoscience and Nanotechnology

Volumn 10, Issue 12, 2010, Pages 7971-7975

  Mognetti, Barbara ^a   Barberis, Alessandro ^a   Marino, Silvia ^a   Di Carlo, Francesco ^a   Lysenko, Vladimir ^b   Marty, Olivier ^b   Géloën, Alain ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Antineoplastic drugs; Cancer; Preferential killing; Quantum dots; Silicon carbide

Indexed keywords

ANTI-PROLIFERATIVE; ANTINEOPLASTIC DRUGS; BIOMEDICAL APPLICATIONS; CANCER; CANCER CELLS; CULTURE MEDIUM; CULTURED CELL; IMMORTALIZED CELLS; IN-VITRO; LOCALISATION; MORPHOLOGICAL CHANGES; PREFERENTIAL KILLING; QUANTUM DOT; QUANTUM DOTS; SQUAMOUS CARCINOMA; TIME-DEPENDENT;

CELL CULTURE; DISEASES; EPITAXIAL GROWTH; SILICON CARBIDE;

SEMICONDUCTOR QUANTUM DOTS;

ANTINEOPLASTIC AGENT; INORGANIC COMPOUND; NANOCONJUGATE; QUANTUM DOT; SILICON CARBIDE; SILICON DERIVATIVE;

ARTICLE; CELL LINE; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; METABOLISM; MOUTH TUMOR; SQUAMOUS CELL CARCINOMA; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARBON COMPOUNDS, INORGANIC; CARCINOMA, SQUAMOUS CELL; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MOUTH NEOPLASMS; NANOCONJUGATES; QUANTUM DOTS; SILICON COMPOUNDS;

EID: 79952108554     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2010.3049     Document Type: Article

References (19)

1. P. Kopf-Maier, Eur. J. Clin. Pharmacol. 47, 1 (1994).
2. R. Huang, A. Wallqvist, and D. G. Covell, Biochem. Pharmacol. 69, 1009 (2005).
3. I. Ott and R. Gust, Arch. Pharm. 340, 117 (2007).
4. C. Infante-Rivard, A. Dufresne, B. Armstrong, P. Bouchard, and G. Theriault, Am. J. Epidemiol. 140, 1009 (1994).
5. K. Rodelsperger and B. Bruckel, Inhal. Toxicol. 18, 623 (2006).
6. R. Yakimova, R. Petoral, G. Yazdi, C. Vahlberg, A. Lloyd Spetz, and K. Uvdal, J. Physics D: Appl. Phys. 40, 1 (2007).
7. H. Song and Z. Zhang, Mater. Sci. Eng.: A 426, 59 (2006).
8. P. González, J. Serra, S. Liste, S. Chiussi, B. León, M. Pérez-Amor, J. Martínez-Fernández, A. R. de Arellano-López, and F. M. Varela-Feria, Biomaterials 24, 4827 (2003).
9. N. Nurdin, P. François, Y. Mugnier, J. Krumeich, M. Moret, B. O. Aronsson, and P. Descouts, Eur. Cell. Mater. 5, 17 (2003).
10. A. J. Rosenbloom, D. M. Sipe, Y. Shishkin, Y. Ke, R. P. Devaty, and W. J. Choyke, Biomed. Microdevices 6, 261 (2004).
11. R. Gómez, A. Ivorra, R. Villa, P. Godignon, J. Millán, I. Erill, A. Solà, G. Hotter, and L. Palacios, Biomed. Microdevices 8, 43 (2006).
12. J. M. Hsu, P. Tathireddy, L. Rieth, A. R. Normann, and F. Solzbacher, Thin Solid Films 516, 34 (2007).
13. J. Fan, H. Li, J. Jiang, L. So, Y. Wan Lam, and P. K. Chu, Small 4, 1058 (2008).
14. J. Botsoa, V. Lysenko, A. Géloën, O. Marty, J. Bluet, and G. Guillot, Appl. Phys. Lett. 92, 173902 (2008).
15. A. Halimaoui, Properties of Porous Silicon, edited by L. T. Canham, INSPEC, The IEE, London, United Kingdom (1997), p. 12.
16. M. P. Hier, M. J. Black, G. Shenouda, N. Sadeghi, and S. E. Karp, Laryngoscope 105, 1077 (1995).
17. J. H. Weisburg, D. B. Weissman, T. Sedaghat, and H. Babich, Basic Clin. Pharmacol. Toxicol. 95, 191 (2004).
18. Y. Zakharko, J. Botsoa, S. Alekseev, V. Lysenko, J.-M. Bluet, O. Marty, V. A. Skryshevsky, and G. Guillot, J. Appl. Phys. 107, 013503 (2010).
19. N. Korolev, O. V. Vorontsova, and L. Nordenskiold, Prog. Biophys. Mol. Biol. 95, 23 (2007).